Cargando…

Increased risk of hospitalisation and intensive care admission associated with reported cases of SARS-CoV-2 variants B.1.1.7 and B.1.351 in Norway, December 2020 –May 2021

INTRODUCTION: Since their emergence, SARS-CoV-2 variants of concern (VOC) B.1.1.7 and B.1.351 have spread worldwide. We estimated the risk of hospitalisation and admission to an intensive care unit (ICU) for infections with B.1.1.7 and B.1.351 in Norway, compared to infections with non-VOC. MATERIAL...

Descripción completa

Detalles Bibliográficos
Autores principales: Veneti, Lamprini, Seppälä, Elina, Larsdatter Storm, Margrethe, Valcarcel Salamanca, Beatriz, Alnes Buanes, Eirik, Aasand, Nina, Naseer, Umaer, Bragstad, Karoline, Hungnes, Olav, Bøås, Håkon, Kvåle, Reidar, Golestani, Karan, Feruglio, Siri, Vold, Line, Nygård, Karin, Whittaker, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504717/
https://www.ncbi.nlm.nih.gov/pubmed/34634066
http://dx.doi.org/10.1371/journal.pone.0258513
_version_ 1784581374804492288
author Veneti, Lamprini
Seppälä, Elina
Larsdatter Storm, Margrethe
Valcarcel Salamanca, Beatriz
Alnes Buanes, Eirik
Aasand, Nina
Naseer, Umaer
Bragstad, Karoline
Hungnes, Olav
Bøås, Håkon
Kvåle, Reidar
Golestani, Karan
Feruglio, Siri
Vold, Line
Nygård, Karin
Whittaker, Robert
author_facet Veneti, Lamprini
Seppälä, Elina
Larsdatter Storm, Margrethe
Valcarcel Salamanca, Beatriz
Alnes Buanes, Eirik
Aasand, Nina
Naseer, Umaer
Bragstad, Karoline
Hungnes, Olav
Bøås, Håkon
Kvåle, Reidar
Golestani, Karan
Feruglio, Siri
Vold, Line
Nygård, Karin
Whittaker, Robert
author_sort Veneti, Lamprini
collection PubMed
description INTRODUCTION: Since their emergence, SARS-CoV-2 variants of concern (VOC) B.1.1.7 and B.1.351 have spread worldwide. We estimated the risk of hospitalisation and admission to an intensive care unit (ICU) for infections with B.1.1.7 and B.1.351 in Norway, compared to infections with non-VOC. MATERIALS AND METHODS: Using linked individual-level data from national registries, we conducted a cohort study on laboratory-confirmed cases of SARS-CoV-2 in Norway diagnosed between 28 December 2020 and 2 May 2021. Variants were identified based on whole genome sequencing, partial sequencing by Sanger sequencing or PCR screening for selected targets. The outcome was hospitalisation or ICU admission. We calculated adjusted risk ratios (aRR) with 95% confidence intervals (CIs) using multivariable binomial regression to examine the association between SARS-CoV-2 variants B.1.1.7 and B.1.351 with i) hospital admission and ii) ICU admission compared to non-VOC. RESULTS: We included 23,169 cases of B.1.1.7, 548 B.1.351 and 4,584 non-VOC. Overall, 1,017 cases were hospitalised (3.6%) and 206 admitted to ICU (0.7%). B.1.1.7 was associated with a 1.9-fold increased risk of hospitalisation (aRR 95%CI 1.6–2.3) and a 1.8-fold increased risk of ICU admission (aRR 95%CI 1.2–2.8) compared to non-VOC. Among hospitalised cases, no difference was found in the risk of ICU admission between B.1.1.7 and non-VOC. B.1.351 was associated with a 2.4-fold increased risk of hospitalisation (aRR 95%CI 1.7–3.3) and a 2.7-fold increased risk of ICU admission (aRR 95%CI 1.2–6.5) compared to non-VOC. DISCUSSION: Our findings add to the growing evidence of a higher risk of severe disease among persons infected with B.1.1.7 or B.1.351. This highlights the importance of prevention and control measures to reduce transmission of these VOC in society, particularly ongoing vaccination programmes, and preparedness plans for hospital surge capacity.
format Online
Article
Text
id pubmed-8504717
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-85047172021-10-12 Increased risk of hospitalisation and intensive care admission associated with reported cases of SARS-CoV-2 variants B.1.1.7 and B.1.351 in Norway, December 2020 –May 2021 Veneti, Lamprini Seppälä, Elina Larsdatter Storm, Margrethe Valcarcel Salamanca, Beatriz Alnes Buanes, Eirik Aasand, Nina Naseer, Umaer Bragstad, Karoline Hungnes, Olav Bøås, Håkon Kvåle, Reidar Golestani, Karan Feruglio, Siri Vold, Line Nygård, Karin Whittaker, Robert PLoS One Research Article INTRODUCTION: Since their emergence, SARS-CoV-2 variants of concern (VOC) B.1.1.7 and B.1.351 have spread worldwide. We estimated the risk of hospitalisation and admission to an intensive care unit (ICU) for infections with B.1.1.7 and B.1.351 in Norway, compared to infections with non-VOC. MATERIALS AND METHODS: Using linked individual-level data from national registries, we conducted a cohort study on laboratory-confirmed cases of SARS-CoV-2 in Norway diagnosed between 28 December 2020 and 2 May 2021. Variants were identified based on whole genome sequencing, partial sequencing by Sanger sequencing or PCR screening for selected targets. The outcome was hospitalisation or ICU admission. We calculated adjusted risk ratios (aRR) with 95% confidence intervals (CIs) using multivariable binomial regression to examine the association between SARS-CoV-2 variants B.1.1.7 and B.1.351 with i) hospital admission and ii) ICU admission compared to non-VOC. RESULTS: We included 23,169 cases of B.1.1.7, 548 B.1.351 and 4,584 non-VOC. Overall, 1,017 cases were hospitalised (3.6%) and 206 admitted to ICU (0.7%). B.1.1.7 was associated with a 1.9-fold increased risk of hospitalisation (aRR 95%CI 1.6–2.3) and a 1.8-fold increased risk of ICU admission (aRR 95%CI 1.2–2.8) compared to non-VOC. Among hospitalised cases, no difference was found in the risk of ICU admission between B.1.1.7 and non-VOC. B.1.351 was associated with a 2.4-fold increased risk of hospitalisation (aRR 95%CI 1.7–3.3) and a 2.7-fold increased risk of ICU admission (aRR 95%CI 1.2–6.5) compared to non-VOC. DISCUSSION: Our findings add to the growing evidence of a higher risk of severe disease among persons infected with B.1.1.7 or B.1.351. This highlights the importance of prevention and control measures to reduce transmission of these VOC in society, particularly ongoing vaccination programmes, and preparedness plans for hospital surge capacity. Public Library of Science 2021-10-11 /pmc/articles/PMC8504717/ /pubmed/34634066 http://dx.doi.org/10.1371/journal.pone.0258513 Text en © 2021 Veneti et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Veneti, Lamprini
Seppälä, Elina
Larsdatter Storm, Margrethe
Valcarcel Salamanca, Beatriz
Alnes Buanes, Eirik
Aasand, Nina
Naseer, Umaer
Bragstad, Karoline
Hungnes, Olav
Bøås, Håkon
Kvåle, Reidar
Golestani, Karan
Feruglio, Siri
Vold, Line
Nygård, Karin
Whittaker, Robert
Increased risk of hospitalisation and intensive care admission associated with reported cases of SARS-CoV-2 variants B.1.1.7 and B.1.351 in Norway, December 2020 –May 2021
title Increased risk of hospitalisation and intensive care admission associated with reported cases of SARS-CoV-2 variants B.1.1.7 and B.1.351 in Norway, December 2020 –May 2021
title_full Increased risk of hospitalisation and intensive care admission associated with reported cases of SARS-CoV-2 variants B.1.1.7 and B.1.351 in Norway, December 2020 –May 2021
title_fullStr Increased risk of hospitalisation and intensive care admission associated with reported cases of SARS-CoV-2 variants B.1.1.7 and B.1.351 in Norway, December 2020 –May 2021
title_full_unstemmed Increased risk of hospitalisation and intensive care admission associated with reported cases of SARS-CoV-2 variants B.1.1.7 and B.1.351 in Norway, December 2020 –May 2021
title_short Increased risk of hospitalisation and intensive care admission associated with reported cases of SARS-CoV-2 variants B.1.1.7 and B.1.351 in Norway, December 2020 –May 2021
title_sort increased risk of hospitalisation and intensive care admission associated with reported cases of sars-cov-2 variants b.1.1.7 and b.1.351 in norway, december 2020 –may 2021
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504717/
https://www.ncbi.nlm.nih.gov/pubmed/34634066
http://dx.doi.org/10.1371/journal.pone.0258513
work_keys_str_mv AT venetilamprini increasedriskofhospitalisationandintensivecareadmissionassociatedwithreportedcasesofsarscov2variantsb117andb1351innorwaydecember2020may2021
AT seppalaelina increasedriskofhospitalisationandintensivecareadmissionassociatedwithreportedcasesofsarscov2variantsb117andb1351innorwaydecember2020may2021
AT larsdatterstormmargrethe increasedriskofhospitalisationandintensivecareadmissionassociatedwithreportedcasesofsarscov2variantsb117andb1351innorwaydecember2020may2021
AT valcarcelsalamancabeatriz increasedriskofhospitalisationandintensivecareadmissionassociatedwithreportedcasesofsarscov2variantsb117andb1351innorwaydecember2020may2021
AT alnesbuaneseirik increasedriskofhospitalisationandintensivecareadmissionassociatedwithreportedcasesofsarscov2variantsb117andb1351innorwaydecember2020may2021
AT aasandnina increasedriskofhospitalisationandintensivecareadmissionassociatedwithreportedcasesofsarscov2variantsb117andb1351innorwaydecember2020may2021
AT naseerumaer increasedriskofhospitalisationandintensivecareadmissionassociatedwithreportedcasesofsarscov2variantsb117andb1351innorwaydecember2020may2021
AT bragstadkaroline increasedriskofhospitalisationandintensivecareadmissionassociatedwithreportedcasesofsarscov2variantsb117andb1351innorwaydecember2020may2021
AT hungnesolav increasedriskofhospitalisationandintensivecareadmissionassociatedwithreportedcasesofsarscov2variantsb117andb1351innorwaydecember2020may2021
AT bøashakon increasedriskofhospitalisationandintensivecareadmissionassociatedwithreportedcasesofsarscov2variantsb117andb1351innorwaydecember2020may2021
AT kvalereidar increasedriskofhospitalisationandintensivecareadmissionassociatedwithreportedcasesofsarscov2variantsb117andb1351innorwaydecember2020may2021
AT golestanikaran increasedriskofhospitalisationandintensivecareadmissionassociatedwithreportedcasesofsarscov2variantsb117andb1351innorwaydecember2020may2021
AT ferugliosiri increasedriskofhospitalisationandintensivecareadmissionassociatedwithreportedcasesofsarscov2variantsb117andb1351innorwaydecember2020may2021
AT voldline increasedriskofhospitalisationandintensivecareadmissionassociatedwithreportedcasesofsarscov2variantsb117andb1351innorwaydecember2020may2021
AT nygardkarin increasedriskofhospitalisationandintensivecareadmissionassociatedwithreportedcasesofsarscov2variantsb117andb1351innorwaydecember2020may2021
AT whittakerrobert increasedriskofhospitalisationandintensivecareadmissionassociatedwithreportedcasesofsarscov2variantsb117andb1351innorwaydecember2020may2021